Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rifapentine and Isoniazid for Latent Genital TB in RIF
NCT04528277Phase 3Unknown
- Sponsor
- Huashan Hospital
- Start
- Sep 2020
- Primary completion
- Sep 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of rifapentine and isoniazid in Genital Tuberculosis (GTB) (3 arms), sponsored by Huashan Hospital. Primary endpoints: Clinical pregnancy rates, Ongoing Pregnancy Rate and 1 more. Status: unknown.
02
Drugs
rifapentineisoniazid
03
Conditions
Genital Tuberculosis (GTB)
Beyond the preview
Go deeper on NCT04528277.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04528277.